SynthesisFrontiers in pharmacology2022

Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab.

Fenge Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.